BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 36906437)

  • 1. Surgery and hepatic artery infusion therapy for intrahepatic cholangiocarcinoma.
    Scott A; Wong P; Melstrom LG
    Surgery; 2023 Jul; 174(1):113-115. PubMed ID: 36906437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
    Cercek A; Boerner T; Tan BR; Chou JF; Gönen M; Boucher TM; Hauser HF; Do RKG; Lowery MA; Harding JJ; Varghese AM; Reidy-Lagunes D; Saltz L; Schultz N; Kingham TP; D'Angelica MI; DeMatteo RP; Drebin JA; Allen PJ; Balachandran VP; Lim KH; Sanchez-Vega F; Vachharajani N; Majella Doyle MB; Fields RC; Hawkins WG; Strasberg SM; Chapman WC; Diaz LA; Kemeny NE; Jarnagin WR
    JAMA Oncol; 2020 Jan; 6(1):60-67. PubMed ID: 31670750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.
    Scheuermann U; Kaths JM; Heise M; Pitton MB; Weinmann A; Hoppe-Lotichius M; Otto G
    Eur J Surg Oncol; 2013 Jun; 39(6):593-600. PubMed ID: 23611755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.
    Gusani NJ; Balaa FK; Steel JL; Geller DA; Marsh JW; Zajko AB; Carr BI; Gamblin TC
    J Gastrointest Surg; 2008 Jan; 12(1):129-37. PubMed ID: 17851723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of surgical resection of a combined hepatocellular and cholangiocarcinoma after transarterial chemoembolization].
    Yakoshi Y; Toyoki Y; Ishido K; Kudo D; Kimura N; Wakiya T; Hakamada K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1798-800. PubMed ID: 24393926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of locally advanced intrahepatic cholangiocarcinoma: a narrative review.
    Bressler L; Bath N; Manne A; Miller E; Cloyd JM
    Chin Clin Oncol; 2023 Apr; 12(2):15. PubMed ID: 37038054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone.
    Konstantinidis IT; Groot Koerkamp B; Do RK; Gönen M; Fong Y; Allen PJ; D'Angelica MI; Kingham TP; DeMatteo RP; Klimstra DS; Kemeny NE; Jarnagin WR
    Cancer; 2016 Mar; 122(5):758-65. PubMed ID: 26695839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating unresectable intrahepatic cholangiocarcinoma with transarterial chemoembolization and an unusual progression with cardiac involvement.
    Mumdzhiev N; Borisov B; Tenev R; Radicheva M
    Folia Med (Plovdiv); 2023 Apr; 65(2):326-330. PubMed ID: 37144321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
    Hoffmann RT; Paprottka PM; Schön A; Bamberg F; Haug A; Dürr EM; Rauch B; Trumm CT; Jakobs TF; Helmberger TK; Reiser MF; Kolligs FT
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):105-16. PubMed ID: 21431970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status and perspectives in the surgical and oncological management of intrahepatic cholangiocarcinoma.
    Dhote A; Tzedakis S; Shapira OI; Nassar A; Boudjema K; Fuks D
    J Visc Surg; 2023 Oct; 160(5):346-355. PubMed ID: 37563006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter CT arterial portography and CT hepatic arteriography for liver tumor visualization during percutaneous ablation.
    van Tilborg AA; Scheffer HJ; Nielsen K; van Waesberghe JH; Comans EF; van Kuijk C; van den Tol PM; Meijerink MR
    J Vasc Interv Radiol; 2014 Jul; 25(7):1101-1111.e4. PubMed ID: 24755086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma.
    Franssen S; Soares KC; Jolissaint JS; Tsilimigras DI; Buettner S; Alexandrescu S; Marques H; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Margonis GA; Weiss MJ; Bauer TW; Shen F; Poultsides GA; Marsh JW; Cercek A; Kemeny N; Kingham TP; D'Angelica M; Pawlik TM; Jarnagin WR; Koerkamp BG
    JAMA Surg; 2022 Jul; 157(7):590-596. PubMed ID: 35544131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of a pre-operative radiological scoring system in determining resectability for potentially resectable hilar cholangiocarcinoma.
    Bird N; McKenna A; Dunne D; Francis B; Fenwick S; Poston G; Jones R; Malik H
    Eur J Surg Oncol; 2019 Feb; 45(2):192-197. PubMed ID: 30297275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival.
    Soares KC; Jolissaint JS; McIntyre SM; Seier KP; Gönen M; Sigel C; Nasar N; Cercek A; Harding JJ; Kemeny NE; Connell LC; Koerkamp BG; Balachandran VP; D'Angelica MI; Drebin JA; Kingham TP; Wei AC; Jarnagin WR
    Cancer Med; 2023 Jun; 12(11):12272-12284. PubMed ID: 37062071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging of hilar cholangiocarcinoma with ultrasound.
    Neumaier CE; Bertolotto M; Perrone R; Martinoli C; Loria F; Silvestri E
    J Clin Ultrasound; 1995; 23(3):173-8. PubMed ID: 7730463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review.
    Rizzo A; Brandi G
    Cancer Treat Res Commun; 2021; 27():100354. PubMed ID: 33756174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.
    Lunsford KE; Javle M; Heyne K; Shroff RT; Abdel-Wahab R; Gupta N; Mobley CM; Saharia A; Victor DW; Nguyen DT; Graviss EA; Kaseb AO; McFadden RS; Aloia TA; Conrad C; Li XC; Monsour HP; Gaber AO; Vauthey JN; Ghobrial RM;
    Lancet Gastroenterol Hepatol; 2018 May; 3(5):337-348. PubMed ID: 29548617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular targeted and systemic therapy for intrahepatic cholangiocarcinoma: a multi-disciplinary approach.
    Merath K; Tiwari A; Parikh AA; Pawlik TM
    Future Oncol; 2023 Dec; 19(39):2607-2621. PubMed ID: 38108100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.